Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.

Oceania dividend not expected for 'foreseeable future': Jarden
Property

Oceania dividend not expected for 'foreseeable future': Jarden

The retirement and aged care firm has signalled a change to its dividend policy.

Gregor Thompson 27 May 2025
Health NZ seeks ‘partnerships’ with major health contractors
Policy

Health NZ seeks ‘partnerships’ with major health contractors

The agency is establishing a major projects panel to tackle $6.4b pipeline.

Oliver Lewis 27 May 2025
Radius Care turns first profit in three years
News in Brief

Radius Care turns first profit in three years

Radius Care has reported its first net profit in three years and updated its dividend policy. The listed aged-care specialist reported net profit after tax (npat) of $7.4 million in its full-year financial results for the year to March 31, up from a loss of $8.5m previously.Under...

Gregor Thompson 21 May 2025